2-chloro-n(6)cyclopentyladenosine has been researched along with n(6)-phenyladenosine in 3 studies
Studies (2-chloro-n(6)cyclopentyladenosine) | Trials (2-chloro-n(6)cyclopentyladenosine) | Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine) | Studies (n(6)-phenyladenosine) | Trials (n(6)-phenyladenosine) | Recent Studies (post-2010) (n(6)-phenyladenosine) |
---|---|---|---|---|---|
252 | 0 | 43 | 28 | 0 | 6 |
Protein | Taxonomy | 2-chloro-n(6)cyclopentyladenosine (IC50) | n(6)-phenyladenosine (IC50) |
---|---|---|---|
neuropeptide Y receptor type 1 | Homo sapiens (human) | 7.826 | |
neuropeptide Y receptor type 2 | Homo sapiens (human) | 4.729 | |
Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.0049 | |
Adenosine receptor A2b | Rattus norvegicus (Norway rat) | 0.66 | |
Adenosine receptor A2a | Rattus norvegicus (Norway rat) | 0.66 | |
Adenosine receptor A1 | Gallus gallus (chicken) | 0.0046 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jacobson, KA; van Galen, PJ; Williams, M | 1 |
Daly, JW; Olsson, RA; Secunda, S; Thompson, RD | 1 |
Cappellacci, L; Franchetti, P; Graser, G; Grifantini, M; Jayaram, HN; Lavecchia, A; Petrelli, R; Saiko, P; Szekeres, T; Vita, P | 1 |
1 review(s) available for 2-chloro-n(6)cyclopentyladenosine and n(6)-phenyladenosine
Article | Year |
---|---|
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
Topics: Adenosine; Animals; Humans; Models, Chemical; Receptors, Purinergic; Second Messenger Systems; Structure-Activity Relationship | 1992 |
2 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and n(6)-phenyladenosine
Article | Year |
---|---|
Activity of N6-substituted 2-chloroadenosines at A1 and A2 adenosine receptors.
Topics: 2-Chloroadenosine; Animals; Brain; In Vitro Techniques; Rats; Receptors, Purinergic; Structure-Activity Relationship | 1991 |
Ribose-modified purine nucleosides as ribonucleotide reductase inhibitors. Synthesis, antitumor activity, and molecular modeling of N6-substituted 3'-C-methyladenosine derivatives.
Topics: Adenosine; Antineoplastic Agents; Cell Line, Tumor; Enzyme Inhibitors; Humans; Ribonucleotide Reductases; Ribose; Structure-Activity Relationship | 2008 |